Saturday, 27 July 2024


Indian Immunologicals donates anti-rabies vaccine to economically backward provinces of Vietnam

16 July 2024 | News

IIL is spearheading the “One Health” initiative globally

Indian Immunologicals Ltd (IIL), led by its Chairman Dr Meenesh Shah and Managing Director Dr K. Anand Kumar, has donated 10,000 doses of its anti-rabies vaccine to the economically backward people of 5 provinces in Vietnam.

At a function held in Hanoi chaired by Dr. Huong, Head of the Rabies control programme, Government of Vietnam and participated by many officials from CDC and different provinces and officials from AMV group headed by its CEO Mr. Minh, this generous donation was made.

IIL is a “One Health” company engaged in development of vaccines for zoonotic diseases, responsible manufacturing for environmental protection, imparting knowledge and awareness to all stakeholders on diseases and demonstrates with social responsibility. 

75% of all emerging and re-emerging diseases are from animal origin and IIL used various technology platforms and developed vaccines against zoonotic diseases such as – “Rabies”, “Brucellosis”, “Leptospira”, “Porcine Cysticercosis”, “Covid-19” etc.

Many new vaccines such as “Zika”, “KFD” etc. are under development, against diseases which are Zoonotic in nature. Besides being the largest manufacturer of Anti-Rabies vaccine in the world for both animal and human beings, IIL is spearheading the “One Health” initiative globally.

Speaking on the occasion Dr K. Anand Kumar said "IIL has been supporting many developing countries by supplying vaccines at affordable prices and in Vietnam, IIL's anti rabies vaccine Abhayab is the brand leader having saved several thousands of lives. We have forged a very good partnership with AMV group and DAVAC and have been supplying vaccines in Vietnam for 15 years now''.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account